• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传和炎症生物标志物能否识别临床侵袭性前列腺癌?

Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?

作者信息

Santos Pedro Bargão, Patel Hitendra, Henrique Rui, Félix Ana

机构信息

Department of Urology, Prof. Doutor Fernando Fonseca Hospital, Amadora 2720-276, Portugal.

Department of Urology, University Hospital North Norway, Tromsø 9019, Norway.

出版信息

World J Clin Oncol. 2020 Feb 24;11(2):43-52. doi: 10.5306/wjco.v11.i2.43.

DOI:10.5306/wjco.v11.i2.43
PMID:32133274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7046922/
Abstract

Prostate cancer (PCa) is a highly prevalent malignancy and constitutes a major cause of cancer-related morbidity and mortality. It emerges through the acquisition of genetic and epigenetic alterations. Epigenetic modifications include DNA methylation, histone modifications and microRNA deregulation. These generate heritable transformations in the expression of genes but do not change the DNA sequence. Alterations in DNA methylation (hypo and hypermethylation) are the most characterized in PCa. They lead to genomic instability and inadequate gene expression. Major and minor-specific modifications in chromatin recasting are involved in PCa, with signs suggesting a dysfunction of enzymes modified by histones. MicroRNA deregulation also contributes to the initiation of PCa, including involvement in androgen receptor signalization and apoptosis. The influence of inflammation on prostate tumor carcinogenesis is currently much better known. Recent discoveries about microbial species resident in the urinary tract suggest that these are the initiators of chronic inflammation, promoting prostate inflammatory atrophy and eventually leading to PCa. Complete characterization of the relationship between the urinary microbiome and prostatic chronic inflammation will be crucial to develop plans for the prevention of PCa. The prevalent nature of epigenetic and inflammatory alterations may provide potential biomarkers for PCa diagnosis, treatment decisions, evaluation of prognosis and posttreatment surveillance.

摘要

前列腺癌(PCa)是一种高度常见的恶性肿瘤,是癌症相关发病和死亡的主要原因。它通过获得遗传和表观遗传改变而出现。表观遗传修饰包括DNA甲基化、组蛋白修饰和微小RNA失调。这些会在基因表达中产生可遗传的变化,但不会改变DNA序列。DNA甲基化的改变(低甲基化和高甲基化)在前列腺癌中最为典型。它们会导致基因组不稳定和基因表达不足。染色质重塑中的主要和次要特异性修饰都与前列腺癌有关,有迹象表明存在组蛋白修饰酶功能障碍。微小RNA失调也有助于前列腺癌的发生,包括参与雄激素受体信号传导和细胞凋亡。目前,炎症对前列腺肿瘤致癌作用的影响已广为人知。最近关于尿路中常驻微生物种类的发现表明,这些微生物是慢性炎症的引发者,会促进前列腺炎性萎缩并最终导致前列腺癌。全面了解尿路微生物群与前列腺慢性炎症之间的关系对于制定前列腺癌预防计划至关重要。表观遗传和炎症改变的普遍性质可能为前列腺癌的诊断、治疗决策、预后评估和治疗后监测提供潜在的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/7046922/069bb4ad67bf/WJCO-11-43-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/7046922/069bb4ad67bf/WJCO-11-43-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa12/7046922/069bb4ad67bf/WJCO-11-43-g001.jpg

相似文献

1
Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?表观遗传和炎症生物标志物能否识别临床侵袭性前列腺癌?
World J Clin Oncol. 2020 Feb 24;11(2):43-52. doi: 10.5306/wjco.v11.i2.43.
2
Epigenetics in prostate cancer: biologic and clinical relevance.前列腺癌中的表观遗传学:生物学和临床相关性。
Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22.
3
Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer.表观遗传学与促进前列腺癌雄激素信号转导之间的串扰。
Vitam Horm. 2023;122:253-282. doi: 10.1016/bs.vh.2022.11.007. Epub 2022 Dec 29.
4
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.前列腺癌中EFEMP1的表观遗传调控:生物学相关性及临床潜力
J Cell Mol Med. 2014 Nov;18(11):2287-97. doi: 10.1111/jcmm.12394. Epub 2014 Sep 11.
5
Epigenomics in stress tolerance of plants under the climate change.植物在气候变化下的应激耐受中的表观基因组学。
Mol Biol Rep. 2023 Jul;50(7):6201-6216. doi: 10.1007/s11033-023-08539-6. Epub 2023 Jun 9.
6
The genetics of neuroendocrine prostate cancers: a review of current and emerging candidates.神经内分泌前列腺癌的遗传学:对当前及新出现候选基因的综述
Appl Clin Genet. 2012 Nov 8;5:105-10. doi: 10.2147/TACG.S28881. Print 2012.
7
Epigenetic modifications in prostate cancer.前列腺癌中的表观遗传修饰
Epigenomics. 2014;6(4):415-26. doi: 10.2217/epi.14.34.
8
Aberrant DNA methylation and prostate cancer.异常的 DNA 甲基化与前列腺癌。
Curr Genomics. 2011 Nov;12(7):486-505. doi: 10.2174/138920211797904061.
9
The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.表观遗传学在前列腺癌和良性前列腺增生的发生、诊断及治疗中的作用不断扩展。
J Urol. 2007 Mar;177(3):822-31. doi: 10.1016/j.juro.2006.10.063.
10
Epigenetic Modifications and Modulators in Prostate Cancer.前列腺癌中的表观遗传修饰与调节剂
Crit Rev Oncog. 2017;22(5-6):439-450. doi: 10.1615/CritRevOncog.2017020964.

引用本文的文献

1
Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.蛋白磷酸酶 2A(PP2A)的偏倚全酶组装:从癌症到小分子。
J Biol Chem. 2022 Dec;298(12):102656. doi: 10.1016/j.jbc.2022.102656. Epub 2022 Nov 1.
2
Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer.关键表观遗传调节因子在前列腺癌基因转录和进展中的作用
Front Mol Biosci. 2021 Dec 15;8:743376. doi: 10.3389/fmolb.2021.743376. eCollection 2021.
3
Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy.

本文引用的文献

1
Epigenetic modifications of histones in cancer.癌症中组蛋白的表观遗传修饰。
Genome Biol. 2019 Nov 20;20(1):245. doi: 10.1186/s13059-019-1870-5.
2
Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.比较组织活检和尿液前列腺癌患者中两个基因启动子甲基化panel 的诊断和预后性能。
Clin Epigenetics. 2018 Oct 29;10(1):132. doi: 10.1186/s13148-018-0564-2.
3
Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the 'Biomarker Laboratory'.
格拉斯哥预后评分在含铂细胞毒化疗后接受免疫治疗的 NSCLC 患者中的意义。
In Vivo. 2021 Nov-Dec;35(6):3423-3430. doi: 10.21873/invivo.12642.
4
Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans.miR-182/PDCD4轴在非裔美国人前列腺癌侵袭性中的作用
BMC Cancer. 2021 Sep 15;21(1):1028. doi: 10.1186/s12885-021-08723-6.
5
The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.良性前列腺增生和前列腺癌的病因学与病理生理学起源:一个新视角。
Medicines (Basel). 2021 Jun 11;8(6):30. doi: 10.3390/medicines8060030.
6
Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.计算机分析丁香酚在脂氧合酶和环氧化酶通路中的抑制活性。
Sci Rep. 2020 Oct 1;10(1):16204. doi: 10.1038/s41598-020-73203-z.
7
Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.前列腺癌管理:长期观念、21世纪初的流行趋势及三维解决方案
EPMA J. 2020 Jun 26;11(3):399-418. doi: 10.1007/s13167-020-00214-1. eCollection 2020 Sep.
七种新型前列腺癌生物标志物的定量分析及“生物标志物实验室”的潜在未来
Diagnostics (Basel). 2018 Jul 27;8(3):49. doi: 10.3390/diagnostics8030049.
4
The inflammatory microenvironment and microbiome in prostate cancer development.前列腺癌发展中的炎症微环境和微生物组。
Nat Rev Urol. 2018 Jan;15(1):11-24. doi: 10.1038/nrurol.2017.167. Epub 2017 Oct 31.
5
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.前列腺癌基质中 PDGFR-β 的高表达与临床和生化前列腺癌复发独立相关。
Sci Rep. 2017 Feb 24;7:43378. doi: 10.1038/srep43378.
6
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.MiR-193b启动子甲基化可准确检测尿沉渣中的前列腺癌,而miR-34b/c或miR-129-2启动子甲基化可界定临床侵袭性肿瘤的亚组。
Mol Cancer. 2017 Jan 31;16(1):26. doi: 10.1186/s12943-017-0604-0.
7
Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.炎症诱导的氧化应激介导前列腺癌中的基因融合形成。
Cell Rep. 2016 Dec 6;17(10):2620-2631. doi: 10.1016/j.celrep.2016.11.019.
8
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.低CD38可识别类似祖细胞的炎症相关管腔细胞,这些细胞可引发人类前列腺癌并预测不良预后。
Cell Rep. 2016 Dec 6;17(10):2596-2606. doi: 10.1016/j.celrep.2016.11.010.
9
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.PCAT14作为前列腺癌预后生物标志物的鉴定与验证
Neoplasia. 2016 Aug;18(8):489-99. doi: 10.1016/j.neo.2016.07.001.
10
Circulating long non-coding RNAs in cancer: current status and future perspectives.癌症中的循环长链非编码RNA:现状与未来展望
Mol Cancer. 2016 May 17;15(1):39. doi: 10.1186/s12943-016-0524-4.